Sernova Biotherapeutics Overview
- Year Founded
-
1998
- Status
-
Public
- Employees
-
8
- Stock Symbol
-
SVA
- Investments
-
3
- Share Price
-
$0.06
- (As of Friday Closing)
Sernova Biotherapeutics General Information
Description
Sernova Biotherapeutics Inc is a clinical-stage biotechnology company focused on advancing regenerative medicine for the treatment of chronic diseases. The Company's primary asset is its proprietary Cell Pouch, a bio-hybrid organ system designed to enhance the delivery of cell therapy by replicating natural body functions. The Cell Pouch creates a vascularized, organ-like environment that promotes the longevity and functionality of therapeutic cells and ensures containment for retrievability.
Contact Information
Website
www.sernova.comCorporate Office
- RPO Central Parkway
- PO Box 29592
- Mississauga, Ontario L5A 4H2
- Canada
Corporate Office
- RPO Central Parkway
- PO Box 29592
- Mississauga, Ontario L5A 4H2
- Canada
Sernova Biotherapeutics Timeline
Sernova Biotherapeutics Stock Performance
As of 20-Nov-2026, Sernova Biotherapeutics’s stock price is $0.06. Its current market cap is $23.7M with 378M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.06 | $0.06 | $0.06 - $0.14 | $23.7M | 378M | 210K | -$0.05 |
Sernova Biotherapeutics Financials Summary
As of 31-Jul-2026, Sernova Biotherapeutics has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 31-Jul-2026 | FY 2025 31-Oct-2025 | FY 2024 31-Oct-2024 | FY 2023 31-Oct-2023 |
|---|---|---|---|---|
| EV | 39,226 | 45,671 | 55,290 | 144,378 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (6,485) | (10,453) | (23,102) | (29,652) |
| Net Income | (7,424) | (11,223) | (23,649) | (28,894) |
| Total Assets | 267 | 547 | 5,412 | 15,985 |
| Total Debt | 1,844 | 3,414 | 410 | 98 |
Sernova Biotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sernova Biotherapeutics Comparisons
Industry
Financing
Details
Sernova Biotherapeutics Competitors (42)
One of Sernova Biotherapeutics’s 42 competitors is Viridian Therapeutics, a Formerly VC-backed company based in Waltham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Viridian Therapeutics | Formerly VC-backed | Waltham, MA | ||||
| Regenerative Medical Solutions | Venture Capital-Backed | Madison, WI | ||||
| Orgenesis | Corporation | Germantown, MD | ||||
| Jnana Therapeutics | Formerly VC-backed | Boston, MA | ||||
| CalciMedica | Formerly VC-backed | La Jolla, CA |
Sernova Biotherapeutics Signals
Sernova Biotherapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Sernova Biotherapeutics Investments & Acquisitions (3)
Sernova Biotherapeutics’s most recent deal was a Merger/Acquisition with Seraxis. The deal was made on 08-Sep-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Seraxis | 08-Sep-2026 | Merger/Acquisition | Biotechnology | ||
| Converge Biotech (Conformal Coating Technology) | 15-Jun-2020 | Corporate Asset Purchase | Buildings and Property | ||
| Mecca Medi-Tech | 28-Feb-2000 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
Sernova Biotherapeutics ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Sernova Biotherapeutics FAQs
-
When was Sernova Biotherapeutics founded?
Sernova Biotherapeutics was founded in 1998.
-
Where is Sernova Biotherapeutics headquartered?
Sernova Biotherapeutics is headquartered in Mississauga, Canada.
-
What is the size of Sernova Biotherapeutics?
Sernova Biotherapeutics has 8 total employees.
-
What industry is Sernova Biotherapeutics in?
Sernova Biotherapeutics’s primary industry is Drug Discovery.
-
Is Sernova Biotherapeutics a private or public company?
Sernova Biotherapeutics is a Public company.
-
What is Sernova Biotherapeutics’s stock symbol?
The ticker symbol for Sernova Biotherapeutics is SVA.
-
What is the current stock price of Sernova Biotherapeutics?
As of 20-Nov-2026 the stock price of Sernova Biotherapeutics is $0.06.
-
What is the current market cap of Sernova Biotherapeutics?
The current market capitalization of Sernova Biotherapeutics is $23.7M.
-
Who are Sernova Biotherapeutics’s competitors?
Viridian Therapeutics, Regenerative Medical Solutions, Orgenesis, Jnana Therapeutics, and CalciMedica are some of the 42 competitors of Sernova Biotherapeutics.
-
What is Sernova Biotherapeutics’s annual earnings per share (EPS)?
Sernova Biotherapeutics’s EPS for 12 months was -$0.05.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process